The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

LINK TO FULL STUDY: https://pubmed.ncbi.nlm.nih.gov/34841223/

Only people mentioned by @JaneKKAG in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Jane KKAG, click on at the bottom under it